Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua-Reference-Cited by-同舟云学术

Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua

Published:2015-10 Issue:19 Volume:24 Page:2269-2279
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Moll Guido¹²³,Ignatowicz Lech⁴,Catar Rusan³,Luecht Christian³,Sadeghi Behnam¹⁵,Hamad Osama⁶,Jungebluth Philipp⁷⁸,Dragun Duska²³,Schmidtchen Artur⁴,Ringdén Olle¹⁵

Affiliation:

1. Therapeutic Immunology (TIM), Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

2. Berlin-Brandenburg School for Regenerative Therapies (BSRT), Charité Universtätsmedizin Berlin, Berlin, Germany.

3. Department of Nephrology and Intensive Care Medicine, Charité Universtätsmedizin Berlin, Berlin, Germany.

4. Department of Clinical Sciences, Lund University, Lund, Sweden.

5. Center for Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden.

6. Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Stockholm, Sweden.

7. Advanced Center for Translational Regenerative Medicine (ACTREM), Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.

8. Department of Thoracic Surgery, Thoraxklinik, Heidelberg University, Heidelberg, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2015.0120

Reference55 articles.

1. Mesenchymal Stromal Cell Characteristics Vary Depending on Their Origin

2. Immunological Properties of Extraembryonic Human Mesenchymal Stromal Cells Derived from Gestational Tissue

3. Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells

4. Functional Network Analysis of the Transcriptomes of Mesenchymal Stem Cells Derived from Amniotic Fluid, Amniotic Membrane, Cord Blood, and Bone Marrow

5. Are Clinical Trials With Mesenchymal Stem/Progenitor Cells too Far Ahead of the Science? Lessons From Experimental Hematology

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The IL-6 signaling pathway contributes critically to the immunomodulatory mechanism of human decidua-derived mesenchymal stromal cells;iScience;2024-05

2. Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules;Biomarker Research;2024-03-21

3. Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells;In Vitro Cellular & Developmental Biology - Animal;2024-02-29

4. Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem/stromal cell infusions: re-evaluating the dogma;Stem Cell Research & Therapy;2024-02-27

5. Low molecular weight heparin decreases pro-coagulant activity in clinical MSC products;Cytotherapy;2024-02